New OTCs give lip service to canker sores

News
Article

Winter weather and seasonal ailments can take a toll on delicate lips. Every year, consumers rush to their pharmacies in search of relief from cold sores and chapped lips, and if the following new products are any indication, there will be much to choose from this time around.

Related Content
FDA Approves Generic OTC Naloxone Nasal Spray

FDA Approves Generic OTC Naloxone Nasal Spray

April 25th 2024
Article

Amneal Pharmaceuticals said its generic naloxone hydrochloride nasal spray is now available in the US following FDA approval.

Over the Counter podcast

Episode 8: Stay in Sync with Innovations in Medication Decision Support

August 6th 2020
Podcast

Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.

FDA Issues CRL for Epidermolysis Bullosa Gene Therapy

FDA Issues CRL for Epidermolysis Bullosa Gene Therapy

April 23rd 2024
Article

Abeona Therapeutics’ pz-cel is an investigational autologous, COL7A1 gene-corrected epidermal sheet therapy for the treatment of recessive dystrophic epidermolysis bullosa.

FDA Roundup: Biosimilars, Boxed Warning Added for CAR T-Cell Therapies

FDA Roundup: Biosimilars, Boxed Warning Added for CAR T-Cell Therapies

April 19th 2024
Article

Check out important updates from the FDA for the week of April 15.

Stelara Biosimilar Ustekinumab-aekn Recieves FDA Approval

Stelara Biosimilar Ustekinumab-aekn Recieves FDA Approval

April 19th 2024
Article

This approval is the second biosimilar approval for manufacturer Alvotech.

FDA Accepts GSK's BLA for 5-in-1 Meningococcal Vaccine

FDA Accepts GSK's BLA for 5-in-1 Meningococcal Vaccine

April 16th 2024
Article

The company’s investigational ABCWY vaccine candidate will be reviewed by the FDA by February 14, 2025.

© 2024 MJH Life Sciences

All rights reserved.